|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 24420 |
FusionGeneSummary for NKAIN3_TOX |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: NKAIN3_TOX | Fusion gene ID: 24420 | Hgene | Tgene | Gene symbol | NKAIN3 | TOX | Gene ID | 286183 | 9760 |
| Gene name | sodium/potassium transporting ATPase interacting 3 | thymocyte selection associated high mobility group box | |
| Synonyms | FAM77D | TOX1 | |
| Cytomap | 8q12.3 | 8q12.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 3Na+/K+ transporting ATPase interacting 3family with sequence similarity 77, member D | thymocyte selection-associated high mobility group box protein TOXthymus high mobility group box protein TOX | |
| Modification date | 20180523 | 20180522 | |
| UniProtAcc | Q8N8D7 | O94900 | |
| Ensembl transtripts involved in fusion gene | ENST00000519049, ENST00000523211, ENST00000328472, | ENST00000361421, | |
| Fusion gene scores | * DoF score | 3 X 2 X 3=18 | 4 X 4 X 4=64 |
| # samples | 3 | 6 | |
| ** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(6/64*10)=-0.0931094043914815 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: NKAIN3 [Title/Abstract] AND TOX [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | SKCM | TCGA-WE-AAA3-06A | NKAIN3 | chr8 | 63161686 | + | TOX | chr8 | 59720828 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 3UTR-3CDS | ENST00000519049 | ENST00000361421 | NKAIN3 | chr8 | 63161686 | + | TOX | chr8 | 59720828 | - |
| In-frame | ENST00000523211 | ENST00000361421 | NKAIN3 | chr8 | 63161686 | + | TOX | chr8 | 59720828 | - |
| In-frame | ENST00000328472 | ENST00000361421 | NKAIN3 | chr8 | 63161686 | + | TOX | chr8 | 59720828 | - |
Top |
FusionProtFeatures for NKAIN3_TOX |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| NKAIN3 | TOX |
| May play a role in regulating T-cell development.{ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NKAIN3_TOX |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_NKAIN3_ENST00000523211_chr8_63161686_+_TOX_ENST00000361421_chr8_59720828_-_81aa >In-frame_NKAIN3_ENST00000328472_chr8_63161686_+_TOX_ENST00000361421_chr8_59720828_-_81aa |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_NKAIN3_ENST00000523211_chr8_63161686_+_TOX_ENST00000361421_chr8_59720828_-_243nt ATGGGCTGCTGCACCGGACGCTGCTCGCTCATCTGCCTCTGCGCGCTGCAGTTGGGATTTACTCTTCAACCCGACTATCAGACTATTATC AATCCTACATCTACAGCTGCACAAGTTGTCACCCAGGCAATGGAGTATGTGCGTTCGGGGTGCAGAAATCCTCCCCCACAACCGGTGGAC >In-frame_NKAIN3_ENST00000328472_chr8_63161686_+_TOX_ENST00000361421_chr8_59720828_-_243nt ATGGGCTGCTGCACCGGACGCTGCTCGCTCATCTGCCTCTGCGCGCTGCAGTTGGGATTTACTCTTCAACCCGACTATCAGACTATTATC AATCCTACATCTACAGCTGCACAAGTTGTCACCCAGGCAATGGAGTATGTGCGTTCGGGGTGCAGAAATCCTCCCCCACAACCGGTGGAC |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_NKAIN3_ENST00000523211_chr8_63161686_+_TOX_ENST00000361421_chr8_59720828_-_2704nt AGCCGCGAGCGGCGGCCGCGGGGCCGAGGAGCCTGGGCCGGGCCGGGCGGGGACTACTCCGGAGTCAGGAGGCAGCAGCGGCGGAGGACG AGGATCTCTGGCAGTCAGCGCCGCTCGGACGCCGCCGGCACCATGGGCTGCTGCACCGGACGCTGCTCGCTCATCTGCCTCTGCGCGCTG CAGTTGGGATTTACTCTTCAACCCGACTATCAGACTATTATCAATCCTACATCTACAGCTGCACAAGTTGTCACCCAGGCAATGGAGTAT GTGCGTTCGGGGTGCAGAAATCCTCCCCCACAACCGGTGGACTGGAATAACGACTACTGCAGTAGTGGGGGCATGCAGAGGGACAAAGCA CTGTACCTTACTTGAGAATCTGAACACCTCTTCTTTCCACTGAGGAATTCAGGGAAGTGTTTTCACCATGGATTGCTTTGTACAGTCAAG GCAGTTCTCCATTTTATTAGAAAATACAAGTTGCTAAGCACTTAGGACCATTTGAGCTTGTGGGTCACCCACTCTGGAAGAAATAGTCAT GCTTCTTTATTATTTTTTTAATCCTTTATGGACATTGTTTTTCTTCTTCCCTGAAGGAAATTTGGACCATTCAGATTTTATGTTGGTTTT TTGCTGTGAAGTGCTGCGCTCTAGTAACTGCCTTAGCAACTGTAGATGTCTCGGATAAAAGTCCTGGATTTTCCATTGGTTTTCATAATG GGTGTTTATATGAAACTACTAAAGACTTTTTAAATGGCTTGATGTAGCAGTCATAGCAAGTTTGTAAATAGCATCTATGTTACACTCTCC TAGAGTATAAAATGTGAATGTTTTTGTAGCTAAATTGTAATTGAAACTGGCTCATTCCAGTTTATTGATTTCACAATAGGGGTTAAATTG GCAAACATTCATATTTTTACTTCATTTTTAAAACAACTGACTGATAGTTCTATATTTTCAAAATATTTGAAAATAAAAAGTATTCCCAAG TGATTTTAATTTAAAAACAAATTGGCTTTGTCTCATTGATCAGACAAAAAGAAACTAGTATTAAGGGAAGCGCAAACACATTTATTTTGT ACTGCAGAAAAATTGCTTTTTTGTATCACTTTTTGTGTAATGGTTAGTAAATGTCATTTAAGTCCTTTTATGTATAAAACTGCCAAATGC TTACCTGGTATTTTATTAGATGCAGAAACAGATTGGAAACAGCTAAATTACAACTTTTACATATGGCTCTGTCTTATTGTTTCTTCATAC TGTGTCTGTATTTAATCTTTTTTTATGGAACCTGTTGCGCCTATTTATGAAATAATAAATATAGGTGTTTGTAAGTAAATTTGTTAGTAT TTGAAAGAGGTTTCTTTGATGTTTTAACTTTTGCTGGCAAAAAAAAATTCACGCTTGGTGTGAATACTTTATTATTTAGTTTTTACAGTA ACATGAATAAAGCCAAACCTGCTTTTCATTTAGCAGCAAATTAAAGTAACCAGTCCTTATTTCTGCATTTCTTTGGTTGATGCAAACAAA AAACTATTATATTTAAGAACTTTATTTCTTCATACGACATAACAGAATTGCCCTCCAAGTCACACAAGCTCCAAGACTAAACAAACAGAC AGGTCCTCTGTCTTAAAAAGGTTACTTCTTGGTTCTCAGCTGGTTCTAGTCAATTCTGAACCACCACCCCCCGCCCCCCGCAAAAAAGTA AAAGTCAAACCAAACTTCCTCAAGCTGCATGCTTTTCACAAAATCCAGAAAGCATTTAAGAATTGAACTAGGGGCTGGAAGAAGTGAAAG GGAAGCATCTAAAAATGAAAGGTGAGTAACCAGATAGCAAAAGAAAAGGGAAAGCCATCCAAATTTGAAAGCTGTTGATAGAAATTGAGA TTCTTGCTGTCTTTTGTGCCTCTACAAGCTACTACTCATTCCAGAATTCCTGGGTCTTCCAAGAGGATTCTTAAGGTACCAGAGATTTGC TAGGGAACCAAAAGTGCTTGAGAATCTGCCTGAGGGCTTGCATAGCTTTCACATTAAAAAAAGAAAAAGCTAGCAGATTTACTCCTTTTT AGGGGATCATATCAAGAAAGTTAGTCTGGTTGGAAACCAAGAGAATGGCTGATGTCTCTTTCTTGGAATATGTGAAATAAATTTAGCAGT TTAACTAAATACAAATATATGCATTGTGTAATCCACTCAGAATTAAACAGACAAAAGGTATGCTTGCTTTGGAATGATTTTAGGCATTGT ACAACCTTGAATCACTTGAGCATGTAATAACTAATAAATAATGCAGATCCATGTGATTATTAAAATGACTGTAGCTGAGAGCTCTAATTT TCCTGTCTTGAAACTGTATAAGAACTCATGTGATTAAGTTCACAGTTTATTGTTTGTCTGTTTAGTATTTTAGAAATATACCAGCACTAC TAATTAACTAATGTCTTTTATTTATTATATTATGATAAAGTAAAAATTTCACTTGCATTAAGTCTAAACTGAGAAGGTAATTACTGGGAG GAGAATGAGCAGCTTTGACTTTGACAGGCGGTTTGTGCAGGAAAGCACAGTGCCGTGTTGTTTACAGCTTTTCTAGAGCAGCTGTGCGAC CAGGGTAGAGAGTGTTGAAATTCAATACCAAATACAGTAAAAACAAATGTAAATAAAAGAAAACACATCATCAATAAAACTGTTATTATG >In-frame_NKAIN3_ENST00000328472_chr8_63161686_+_TOX_ENST00000361421_chr8_59720828_-_2572nt ATGGGCTGCTGCACCGGACGCTGCTCGCTCATCTGCCTCTGCGCGCTGCAGTTGGGATTTACTCTTCAACCCGACTATCAGACTATTATC AATCCTACATCTACAGCTGCACAAGTTGTCACCCAGGCAATGGAGTATGTGCGTTCGGGGTGCAGAAATCCTCCCCCACAACCGGTGGAC TGGAATAACGACTACTGCAGTAGTGGGGGCATGCAGAGGGACAAAGCACTGTACCTTACTTGAGAATCTGAACACCTCTTCTTTCCACTG AGGAATTCAGGGAAGTGTTTTCACCATGGATTGCTTTGTACAGTCAAGGCAGTTCTCCATTTTATTAGAAAATACAAGTTGCTAAGCACT TAGGACCATTTGAGCTTGTGGGTCACCCACTCTGGAAGAAATAGTCATGCTTCTTTATTATTTTTTTAATCCTTTATGGACATTGTTTTT CTTCTTCCCTGAAGGAAATTTGGACCATTCAGATTTTATGTTGGTTTTTTGCTGTGAAGTGCTGCGCTCTAGTAACTGCCTTAGCAACTG TAGATGTCTCGGATAAAAGTCCTGGATTTTCCATTGGTTTTCATAATGGGTGTTTATATGAAACTACTAAAGACTTTTTAAATGGCTTGA TGTAGCAGTCATAGCAAGTTTGTAAATAGCATCTATGTTACACTCTCCTAGAGTATAAAATGTGAATGTTTTTGTAGCTAAATTGTAATT GAAACTGGCTCATTCCAGTTTATTGATTTCACAATAGGGGTTAAATTGGCAAACATTCATATTTTTACTTCATTTTTAAAACAACTGACT GATAGTTCTATATTTTCAAAATATTTGAAAATAAAAAGTATTCCCAAGTGATTTTAATTTAAAAACAAATTGGCTTTGTCTCATTGATCA GACAAAAAGAAACTAGTATTAAGGGAAGCGCAAACACATTTATTTTGTACTGCAGAAAAATTGCTTTTTTGTATCACTTTTTGTGTAATG GTTAGTAAATGTCATTTAAGTCCTTTTATGTATAAAACTGCCAAATGCTTACCTGGTATTTTATTAGATGCAGAAACAGATTGGAAACAG CTAAATTACAACTTTTACATATGGCTCTGTCTTATTGTTTCTTCATACTGTGTCTGTATTTAATCTTTTTTTATGGAACCTGTTGCGCCT ATTTATGAAATAATAAATATAGGTGTTTGTAAGTAAATTTGTTAGTATTTGAAAGAGGTTTCTTTGATGTTTTAACTTTTGCTGGCAAAA AAAAATTCACGCTTGGTGTGAATACTTTATTATTTAGTTTTTACAGTAACATGAATAAAGCCAAACCTGCTTTTCATTTAGCAGCAAATT AAAGTAACCAGTCCTTATTTCTGCATTTCTTTGGTTGATGCAAACAAAAAACTATTATATTTAAGAACTTTATTTCTTCATACGACATAA CAGAATTGCCCTCCAAGTCACACAAGCTCCAAGACTAAACAAACAGACAGGTCCTCTGTCTTAAAAAGGTTACTTCTTGGTTCTCAGCTG GTTCTAGTCAATTCTGAACCACCACCCCCCGCCCCCCGCAAAAAAGTAAAAGTCAAACCAAACTTCCTCAAGCTGCATGCTTTTCACAAA ATCCAGAAAGCATTTAAGAATTGAACTAGGGGCTGGAAGAAGTGAAAGGGAAGCATCTAAAAATGAAAGGTGAGTAACCAGATAGCAAAA GAAAAGGGAAAGCCATCCAAATTTGAAAGCTGTTGATAGAAATTGAGATTCTTGCTGTCTTTTGTGCCTCTACAAGCTACTACTCATTCC AGAATTCCTGGGTCTTCCAAGAGGATTCTTAAGGTACCAGAGATTTGCTAGGGAACCAAAAGTGCTTGAGAATCTGCCTGAGGGCTTGCA TAGCTTTCACATTAAAAAAAGAAAAAGCTAGCAGATTTACTCCTTTTTAGGGGATCATATCAAGAAAGTTAGTCTGGTTGGAAACCAAGA GAATGGCTGATGTCTCTTTCTTGGAATATGTGAAATAAATTTAGCAGTTTAACTAAATACAAATATATGCATTGTGTAATCCACTCAGAA TTAAACAGACAAAAGGTATGCTTGCTTTGGAATGATTTTAGGCATTGTACAACCTTGAATCACTTGAGCATGTAATAACTAATAAATAAT GCAGATCCATGTGATTATTAAAATGACTGTAGCTGAGAGCTCTAATTTTCCTGTCTTGAAACTGTATAAGAACTCATGTGATTAAGTTCA CAGTTTATTGTTTGTCTGTTTAGTATTTTAGAAATATACCAGCACTACTAATTAACTAATGTCTTTTATTTATTATATTATGATAAAGTA AAAATTTCACTTGCATTAAGTCTAAACTGAGAAGGTAATTACTGGGAGGAGAATGAGCAGCTTTGACTTTGACAGGCGGTTTGTGCAGGA AAGCACAGTGCCGTGTTGTTTACAGCTTTTCTAGAGCAGCTGTGCGACCAGGGTAGAGAGTGTTGAAATTCAATACCAAATACAGTAAAA |
Top |
FusionGenePPI for NKAIN3_TOX |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| NKAIN3 | TOX | ZDHHC17, TOX2 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NKAIN3_TOX |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for NKAIN3_TOX |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|